Eli Lilly and Co
LLY
UnitedHealth
UNH
Tractor Supply
TSCO
4
Humana
HUM
5
Builders FirstSource
BLDR
(FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.38%26.51B | 3.68%25.4B | 23.58%24.49B | 37.36%19.82B | -17.03%14.43B | 60.50%17.39B | 17.98%10.84B | 29.08%9.18B | 5.94%7.12B | 18.45%6.72B |
Operating revenue | 4.38%26.51B | 3.68%25.4B | 23.58%24.49B | 37.36%19.82B | -17.03%14.43B | 60.50%17.39B | 17.98%10.84B | 29.08%9.18B | 5.94%7.12B | 18.45%6.72B |
Cost of revenue | 3.80%9.7B | 4.90%9.35B | 17.41%8.91B | 21.58%7.59B | -5.04%6.24B | 65.94%6.57B | 22.94%3.96B | 9.82%3.22B | 8.51%2.93B | 14.82%2.7B |
Gross profit | 4.72%16.81B | 2.98%16.05B | 27.41%15.58B | 49.40%12.23B | -24.31%8.19B | 57.41%10.82B | 15.26%6.87B | 42.60%5.96B | 4.21%4.18B | 21.03%4.01B |
Operating expense | 3.78%13.36B | 3.57%12.87B | 24.42%12.43B | 29.13%9.99B | -13.72%7.74B | 63.95%8.97B | 17.29%5.47B | 60.43%4.66B | 4.46%2.91B | 20.02%2.78B |
Selling and administrative expenses | 3.98%12.53B | 3.28%12.05B | 26.35%11.67B | 31.01%9.24B | -14.55%7.05B | 61.08%8.25B | 15.39%5.12B | 153.60%4.44B | 4.29%1.75B | 22.75%1.68B |
-Selling and marketing expense | 5.06%10.34B | 3.02%9.84B | 31.70%9.55B | 35.87%7.25B | -14.58%5.34B | 51.16%6.25B | 11.73%4.13B | 111.43%3.7B | 4.29%1.75B | 22.75%1.68B |
-General and administrative expense | -0.81%2.19B | 4.49%2.21B | 6.76%2.12B | 15.84%1.98B | -14.45%1.71B | 102.63%2B | 33.74%987M | --738M | ---- | ---- |
Research and development costs | 6.24%630M | -1.17%593M | 3.63%600M | 4.89%579M | 0.73%552M | 188.42%548M | 216.67%190M | -71.96%60M | 0.00%214M | 13.83%214M |
Other operating expenses | 2.44%252M | 12.33%246M | 25.86%219M | 29.85%174M | -20.24%134M | 7.01%168M | -4.27%157M | -81.70%164M | 4.31%896M | 18.32%859M |
Operating profit | 8.50%3.45B | 0.63%3.18B | 40.75%3.16B | 396.24%2.24B | -75.59%452M | 31.91%1.85B | 8.00%1.4B | 1.96%1.3B | 3.66%1.28B | 23.37%1.23B |
Net non-operating interest income expense | -14.29%-160M | 5.41%-140M | -24.37%-148M | 3.25%-119M | 0.00%-123M | -21.78%-123M | -20.24%-101M | -35.48%-84M | 6.06%-62M | -57.14%-66M |
Non-operating interest income | ---- | ---- | -13.33%26M | 36.36%30M | -58.49%22M | 194.44%53M | 63.64%18M | -35.29%11M | 0.00%17M | -5.56%17M |
Non-operating interest expense | 42.24%165M | -25.64%116M | 10.64%156M | 0.00%141M | -17.54%141M | 44.92%171M | 28.26%118M | 29.58%92M | 0.00%71M | 44.90%71M |
Total other finance cost | -120.83%-5M | 33.33%24M | 125.00%18M | 100.00%8M | -20.00%4M | 400.00%5M | -66.67%1M | -62.50%3M | -33.33%8M | 9.09%12M |
Other net income (expense) | ||||||||||
Special income (charges) | ---- | ---- | 150.00%1M | 66.67%-2M | -124.00%-6M | 1,350.00%25M | -104.08%-2M | 208.89%49M | 8.16%-45M | -122.69%-49M |
-Less:Restructuring and merger&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3.13%33M | -57.89%32M |
-Less:Other special charges | ---- | ---- | -150.00%-1M | -66.67%2M | 124.00%6M | -1,350.00%-25M | 104.08%2M | -508.33%-49M | -29.41%12M | 103.13%17M |
Other non- operating income (expenses) | ---- | ---- | ---- | 1,000.00%66M | 103.02%6M | -6,533.33%-199M | 25.00%-3M | ---4M | ---- | ---- |
Income before tax | 8.43%3.29B | 0.10%3.04B | 39.02%3.03B | 596.81%2.18B | -79.60%313M | 19.01%1.53B | 2.55%1.29B | 7.90%1.26B | 3.93%1.17B | -4.92%1.12B |
Income tax | 31.36%800M | -18.91%609M | 29.04%751M | 254.88%582M | -53.14%164M | 151.80%350M | -35.35%139M | -24.56%215M | -7.47%285M | 59.59%308M |
Net income | 2.68%2.49B | 6.36%2.43B | 42.74%2.28B | 972.48%1.6B | -87.43%149M | 3.04%1.19B | 10.36%1.15B | 18.41%1.04B | 8.24%880M | -17.55%813M |
Net income continuous Operations | 2.68%2.49B | 6.36%2.43B | 42.65%2.28B | 973.15%1.6B | -87.42%149M | 2.96%1.18B | 10.36%1.15B | 18.41%1.04B | 8.24%880M | -17.55%813M |
Minority interest income | -3.65%132M | 7.03%137M | -14.67%128M | 134.38%150M | -40.74%64M | 61.19%108M | 3,250.00%67M | -97.01%2M | 19.64%67M | -1.75%56M |
Net income attributable to the parent company | 3.06%2.36B | 6.37%2.29B | 48.62%2.15B | 1,603.53%1.45B | -92.11%85M | -0.55%1.08B | 4.13%1.08B | 27.92%1.04B | 7.40%813M | -18.51%757M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 3.06%2.36B | 6.37%2.29B | 48.62%2.15B | 1,603.53%1.45B | -92.11%85M | -0.55%1.08B | 4.13%1.08B | 27.92%1.04B | 7.40%813M | -18.51%757M |
Basic earnings per share | 1.76%2.6 | 4.93%2.555 | 47.58%2.435 | 1,636.84%1.65 | -92.34%0.095 | -40.38%1.24 | -11.86%2.08 | 24.54%2.36 | 6.16%1.895 | -19.05%1.785 |
Diluted earnings per share | 0.98%2.565 | 5.18%2.54 | 48.62%2.415 | 1,610.53%1.625 | -92.21%0.095 | -40.05%1.22 | -13.59%2.035 | 26.95%2.355 | 6.00%1.855 | -20.63%1.75 |
Dividend per share | 23.43%2.0011 | 32.28%1.6213 | 132.52%1.2256 | -7.53%0.5271 | -44.18%0.57 | 1.0211 | 0 | 33.62%0.7531 | 10.09%0.5637 | 9.10%0.512 |
Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |